83 related articles for article (PubMed ID: 15826873)
1. Preferred conformations of endogenous cannabinoid ligand anandamide.
Chen JZ; Han XW; Xie XQ
Life Sci; 2005 Mar; 76(18):2053-69. PubMed ID: 15826873
[TBL] [Abstract][Full Text] [Related]
2. Exploration of biologically relevant conformations of anandamide, 2-arachidonylglycerol, and their analogues using conformational memories.
Barnett-Norris J; Guarnieri F; Hurst DP; Reggio PH
J Med Chem; 1998 Nov; 41(24):4861-72. PubMed ID: 9822555
[TBL] [Abstract][Full Text] [Related]
3. Endocannabinoid binding to the cannabinoid receptors: what is known and what remains unknown.
Reggio PH
Curr Med Chem; 2010; 17(14):1468-86. PubMed ID: 20166921
[TBL] [Abstract][Full Text] [Related]
4. Amino acid determinants in cyclooxygenase-2 oxygenation of the endocannabinoid anandamide.
Kozak KR; Prusakiewicz JJ; Rowlinson SW; Prudhomme DR; Marnett LJ
Biochemistry; 2003 Aug; 42(30):9041-9. PubMed ID: 12885237
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, conformational analysis and CB1 binding affinity of hairpin-like anandamide pseudopeptide mimetics.
Di Marzo M; Casapullo A; Bifulco G; Cimino P; Ligresti A; Di Marzo V; Riccio R; Gomez-Paloma L
J Pept Sci; 2006 Sep; 12(9):575-91. PubMed ID: 16534762
[TBL] [Abstract][Full Text] [Related]
6. The endocannabinoid system, anandamide and the regulation of mammalian cell apoptosis.
Maccarrone M; Finazzi-Agró A
Cell Death Differ; 2003 Sep; 10(9):946-55. PubMed ID: 12934069
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity analysis of anandamide analogs: relationship to a cannabinoid pharmacophore.
Thomas BF; Adams IB; Mascarella SW; Martin BR; Razdan RK
J Med Chem; 1996 Jan; 39(2):471-9. PubMed ID: 8558515
[TBL] [Abstract][Full Text] [Related]
8. Nuclear magnetic resonance for studying recognition processes between anandamide and cannabinoid receptors.
Bonechi C; Martini S; Brizzi V; Brizzi A; Massarelli P; Bruni G; Rossi C
Eur J Med Chem; 2006 Oct; 41(10):1117-23. PubMed ID: 16837109
[TBL] [Abstract][Full Text] [Related]
9. Cannabinoid CB1 receptor recognition of endocannabinoids via the lipid bilayer: molecular dynamics simulations of CB1 transmembrane helix 6 and anandamide in a phospholipid bilayer.
Lynch DL; Reggio PH
J Comput Aided Mol Des; 2006; 20(7-8):495-509. PubMed ID: 17106765
[TBL] [Abstract][Full Text] [Related]
10. Prediction of essential binding domains for the endocannabinoid N-arachidonoylethanolamine (AEA) in the brain cannabinoid CB1 receptor.
Shim JY
PLoS One; 2021; 16(6):e0229879. PubMed ID: 34181638
[TBL] [Abstract][Full Text] [Related]
11. Mass-spectrometric identification of anandamide and 2-arachidonoylglycerol in nematodes.
Lehtonen M; Reisner K; Auriola S; Wong G; Callaway JC
Chem Biodivers; 2008 Nov; 5(11):2431-41. PubMed ID: 19035572
[TBL] [Abstract][Full Text] [Related]
12. Targeted stable-isotope dilution GC-MS/MS analysis of the endocannabinoid anandamide and other fatty acid ethanol amides in human plasma.
Zoerner AA; Gutzki FM; Suchy MT; Beckmann B; Engeli S; Jordan J; Tsikas D
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Sep; 877(26):2909-23. PubMed ID: 19414283
[TBL] [Abstract][Full Text] [Related]
13. Effects of homologues and analogues of palmitoylethanolamide upon the inactivation of the endocannabinoid anandamide.
Jonsson KO; Vandevoorde S; Lambert DM; Tiger G; Fowler CJ
Br J Pharmacol; 2001 Aug; 133(8):1263-75. PubMed ID: 11498512
[TBL] [Abstract][Full Text] [Related]
14. The conformation, location, and dynamic properties of the endocannabinoid ligand anandamide in a membrane bilayer.
Tian X; Guo J; Yao F; Yang DP; Makriyannis A
J Biol Chem; 2005 Aug; 280(33):29788-95. PubMed ID: 15964843
[TBL] [Abstract][Full Text] [Related]
15. Molecular dynamics simulations of the endocannabinoid N-arachidonoylethanolamine (anandamide) in a phospholipid bilayer: probing structure and dynamics.
Lynch DL; Reggio PH
J Med Chem; 2005 Jul; 48(15):4824-33. PubMed ID: 16033262
[TBL] [Abstract][Full Text] [Related]
16. Anandamide induces necrosis in primary hepatic stellate cells.
Siegmund SV; Uchinami H; Osawa Y; Brenner DA; Schwabe RF
Hepatology; 2005 May; 41(5):1085-95. PubMed ID: 15841466
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of leukocyte function and interleukin-2 gene expression by 2-methylarachidonyl-(2'-fluoroethyl)amide, a stable congener of the endogenous cannabinoid receptor ligand anandamide.
Kaplan BL; Ouyang Y; Herring A; Yea SS; Razdan R; Kaminski NE
Toxicol Appl Pharmacol; 2005 Jun; 205(2):107-15. PubMed ID: 15893538
[TBL] [Abstract][Full Text] [Related]
18. Preparation of monoclonal antibodies reactive to the endogenous small molecule, anandamide.
Basta PV; Adcock AF; Tallent CR; Fleming DN; Seltzman HH; Whisnant CC; Cook CE
J Immunol Methods; 2004 Feb; 285(2):181-95. PubMed ID: 14980433
[TBL] [Abstract][Full Text] [Related]
19. Anandamide activity and degradation are regulated by early postnatal aging and follicle-stimulating hormone in mouse Sertoli cells.
Maccarrone M; Cecconi S; Rossi G; Battista N; Pauselli R; Finazzi-Agrò A
Endocrinology; 2003 Jan; 144(1):20-8. PubMed ID: 12488326
[TBL] [Abstract][Full Text] [Related]
20. Homology model of the CB1 cannabinoid receptor: sites critical for nonclassical cannabinoid agonist interaction.
Shim JY; Welsh WJ; Howlett AC
Biopolymers; 2003; 71(2):169-89. PubMed ID: 12767117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
